...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Question on valuing shares from time of spinoff

It really doesn't matter what your brokerage values it at, it what you valued it at at the time of the split.

tada

5
Sep 13, 2018 08:08AM
1
Sep 13, 2018 09:28AM
2
Sep 13, 2018 11:34AM
Share
New Message
Please login to post a reply